Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer : A Critical Evaluation
To reduce the ambiguity of contradictory observations in different studies regarding the expression level of Macrophage Inhibitory Cytokine-1 (MIC-1) in serum in prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy controls (HC), we designed this double-blind study. The study comprises 240 sera from PC, BPH and HC subjects. The expression level of MIC-1 in PC, BPH and HC were appraised using Western blot (WB) and ELISA based approach. WB and ELISA appraisal reveals that the expression level of MIC-1 is significantly higher in PC than in HC or BPH subjects. Regression analysis revealed a significant correlation between MIC-1 vs. PSA (r = 0.09; p < 0.001) and MIC-1 vs. GS (r = 0.7; p < 0.001). ROC analysis using discriminant predicted probability revealed that the MIC-1 was better than PSA. Moreover, the combination of MIC-1 and PSA was allowing 99.1% AUC for the differentiation of BPH + PC from HC, 97.9% AUC for differentiation of BPH from HC, 98.6% AUC for differentiation of PC from HC, and 96.7% AUC for the differentiation of PC from BPH. The augmented expression of MIC-1 in PC compared to BPH and HC subjects is in concurrent of the over-expression of MIC-1 in PC reports and confiscates the contradictory findings of other studies.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
---|---|
Enthalten in: |
Scientific reports - 7(2017), 1 vom: 04. Dez., Seite 16824 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bansal, Navneeta [VerfasserIn] |
---|
Links: |
---|
Themen: |
EC 3.4.21.77 |
---|
Anmerkungen: |
Date Completed 05.07.2019 Date Revised 05.07.2019 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41598-017-17207-2 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM278691617 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM278691617 | ||
003 | DE-627 | ||
005 | 20231226194549.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41598-017-17207-2 |2 doi | |
028 | 5 | 2 | |a pubmed24n0928.xml |
035 | |a (DE-627)NLM278691617 | ||
035 | |a (NLM)29203798 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bansal, Navneeta |e verfasserin |4 aut | |
245 | 1 | 0 | |a Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer |b A Critical Evaluation |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.07.2019 | ||
500 | |a Date Revised 05.07.2019 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a To reduce the ambiguity of contradictory observations in different studies regarding the expression level of Macrophage Inhibitory Cytokine-1 (MIC-1) in serum in prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy controls (HC), we designed this double-blind study. The study comprises 240 sera from PC, BPH and HC subjects. The expression level of MIC-1 in PC, BPH and HC were appraised using Western blot (WB) and ELISA based approach. WB and ELISA appraisal reveals that the expression level of MIC-1 is significantly higher in PC than in HC or BPH subjects. Regression analysis revealed a significant correlation between MIC-1 vs. PSA (r = 0.09; p < 0.001) and MIC-1 vs. GS (r = 0.7; p < 0.001). ROC analysis using discriminant predicted probability revealed that the MIC-1 was better than PSA. Moreover, the combination of MIC-1 and PSA was allowing 99.1% AUC for the differentiation of BPH + PC from HC, 97.9% AUC for differentiation of BPH from HC, 98.6% AUC for differentiation of PC from HC, and 96.7% AUC for the differentiation of PC from BPH. The augmented expression of MIC-1 in PC compared to BPH and HC subjects is in concurrent of the over-expression of MIC-1 in PC reports and confiscates the contradictory findings of other studies | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a GDF15 protein, human |2 NLM | |
650 | 7 | |a Growth Differentiation Factor 15 |2 NLM | |
650 | 7 | |a Prostate-Specific Antigen |2 NLM | |
650 | 7 | |a EC 3.4.21.77 |2 NLM | |
700 | 1 | |a Kumar, Deepak |e verfasserin |4 aut | |
700 | 1 | |a Gupta, Ashish |e verfasserin |4 aut | |
700 | 1 | |a Chandra, Deepak |e verfasserin |4 aut | |
700 | 1 | |a Sankhwar, Satya Narain |e verfasserin |4 aut | |
700 | 1 | |a Mandhani, Anil |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Scientific reports |d 2011 |g 7(2017), 1 vom: 04. Dez., Seite 16824 |w (DE-627)NLM215703936 |x 2045-2322 |7 nnns |
773 | 1 | 8 | |g volume:7 |g year:2017 |g number:1 |g day:04 |g month:12 |g pages:16824 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41598-017-17207-2 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 7 |j 2017 |e 1 |b 04 |c 12 |h 16824 |